| Year |
Citation |
Score |
| 2024 |
Rui X, Zhao X, Zhang N, Ding Y, Seki C, Ono M, Higuchi M, Zhang MR, Chu Y, Wei R, Xu M, Cheng C, Zuo C, Kimura Y, Ni R, et al. Development of a novel radioiodinated compound for amyloid and tau deposition imaging in Alzheimer's disease and tauopathy mouse models. Neuroimage. 303: 120947. PMID 39571640 DOI: 10.1016/j.neuroimage.2024.120947 |
0.491 |
|
| 2024 |
Sobek J, Li J, Combes BF, Gerez JA, Henrich MT, Geibl FF, Nilsson PR, Shi K, Rominger A, Oertel WH, Nitsch RM, Nordberg A, Ågren H, Ni R. Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein. European Journal of Nuclear Medicine and Molecular Imaging. PMID 38953933 DOI: 10.1007/s00259-024-06806-7 |
0.457 |
|
| 2024 |
Wang L, Tang Z, Li B, Peng Y, Yang X, Xiao Y, Ni R, Qi XL. Myricetin ameliorates cognitive impairment in 3×Tg Alzheimer's disease mice by regulating oxidative stress and tau hyperphosphorylation. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 177: 116963. PMID 38889642 DOI: 10.1016/j.biopha.2024.116963 |
0.351 |
|
| 2024 |
Kong Y, Cao L, Wang J, Zhuang J, Xie F, Zuo C, Huang Q, Shi K, Rominger A, Li M, Wu P, Guan Y, Ni R. In vivo reactive astrocyte imaging using [F]SMBT-1 in tauopathy and familial Alzheimer's disease mouse models: A multi-tracer study. Journal of the Neurological Sciences. 462: 123079. PMID 38878650 DOI: 10.1016/j.jns.2024.123079 |
0.395 |
|
| 2024 |
Kong Y, Cao L, Wang J, Zhuang J, Liu Y, Bi L, Qiu Y, Hou Y, Huang Q, Xie F, Yang Y, Shi K, Rominger A, Guan Y, Jin H, ... Ni R, et al. Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [F]GSK1482160. Acs Chemical Neuroscience. PMID 38776461 DOI: 10.1021/acschemneuro.4c00067 |
0.347 |
|
| 2024 |
Kong Y, Maschio CA, Shi X, Xie F, Zuo C, Konietzko U, Shi K, Rominger A, Xiao J, Huang Q, Nitsch RM, Guan Y, Ni R. Relationship Between Reactive Astrocytes, by [F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of Alzheimer's Disease. Molecular Neurobiology. PMID 38502413 DOI: 10.1007/s12035-024-04106-7 |
0.387 |
|
| 2024 |
Ren W, Ni R. Noninvasive Visualization of Amyloid-Beta Deposits in Alzheimer's Amyloidosis Mice via Fluorescence Molecular Tomography Using Contrast Agent. Methods in Molecular Biology (Clifton, N.J.). 2785: 271-285. PMID 38427199 DOI: 10.1007/978-1-0716-3774-6_16 |
0.428 |
|
| 2023 |
Mrđenović D, Combes BF, Ni R, Zenobi R, Kumar N. Probing Chemical Complexity of Amyloid Plaques in Alzheimer's Disease Mice using Hyperspectral Raman Imaging. Acs Chemical Neuroscience. 15: 78-85. PMID 38096362 DOI: 10.1021/acschemneuro.3c00607 |
0.469 |
|
| 2023 |
Kecheliev V, Boss L, Maheshwari U, Konietzko U, Keller A, Razansky D, Nitsch RM, Klohs J, Ni R. Aquaporin 4 is differentially increased and dislocated in association with tau and amyloid-beta. Life Sciences. 321: 121593. PMID 36934970 DOI: 10.1016/j.lfs.2023.121593 |
0.351 |
|
| 2022 |
Kecheliev V, Spinelli F, Herde A, Haider A, Mu L, Klohs J, Ametamey SM, Ni R. Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer's disease. Frontiers in Aging Neuroscience. 14: 1018610. PMID 36248003 DOI: 10.3389/fnagi.2022.1018610 |
0.441 |
|
| 2022 |
Ren W, Li L, Zhang J, Vaas M, Klohs J, Ripoll J, Wolf M, Ni R, Rudin M. Non-invasive visualization of amyloid-beta deposits in Alzheimer amyloidosis mice using magnetic resonance imaging and fluorescence molecular tomography. Biomedical Optics Express. 13: 3809-3822. PMID 35991935 DOI: 10.1364/BOE.458290 |
0.426 |
|
| 2022 |
Ni R, Chen Z, Deán-Ben XL, Voigt FF, Kirschenbaum D, Shi G, Villois A, Zhou Q, Crimi A, Arosio P, Nitsch RM, Nilsson KPR, Aguzzi A, Helmchen F, Klohs J, et al. Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice. Nature Biomedical Engineering. PMID 35835994 DOI: 10.1038/s41551-022-00906-1 |
0.453 |
|
| 2022 |
Maschio C, Ni R. Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer's Disease and Other Tauopathies. Frontiers in Aging Neuroscience. 14: 838034. PMID 35527737 DOI: 10.3389/fnagi.2022.838034 |
0.477 |
|
| 2022 |
Ni R. Magnetic Resonance Imaging in Tauopathy Animal Models. Frontiers in Aging Neuroscience. 13: 791679. PMID 35145392 DOI: 10.3389/fnagi.2021.791679 |
0.344 |
|
| 2022 |
Vagenknecht P, Luzgin A, Ono M, Ji B, Higuchi M, Noain D, Maschio CA, Sobek J, Chen Z, Konietzko U, Gerez JA, Riek R, Razansky D, Klohs J, Nitsch RM, ... ... Ni R, et al. Non-invasive imaging of tau-targeted probe uptake by whole brain multi-spectral optoacoustic tomography. European Journal of Nuclear Medicine and Molecular Imaging. PMID 35128565 DOI: 10.1007/s00259-022-05708-w |
0.435 |
|
| 2022 |
Cao L, Kong Y, Ji B, Ren Y, Guan Y, Ni R. Positron Emission Tomography in Animal Models of Tauopathies. Frontiers in Aging Neuroscience. 13: 761913. PMID 35082657 DOI: 10.3389/fnagi.2021.761913 |
0.413 |
|
| 2022 |
Zheng Y, Ji B, Chen S, Zhou R, Ni R. The impact of uremic toxins on Alzheimer's disease. Current Alzheimer Research. PMID 35048807 DOI: 10.2174/1567205019666220120113305 |
0.355 |
|
| 2022 |
Ni R, Nitsch RM. Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia. Frontiers in Aging Neuroscience. 13: 751897. PMID 35046791 DOI: 10.3389/fnagi.2021.751897 |
0.387 |
|
| 2021 |
Ni R. Magnetic Resonance Imaging in Animal Models of Alzheimer's Disease Amyloidosis. International Journal of Molecular Sciences. 22. PMID 34884573 DOI: 10.3390/ijms222312768 |
0.402 |
|
| 2021 |
Ni R. Positron Emission Tomography in Animal Models of Alzheimer's Disease Amyloidosis: Translational Implications. Pharmaceuticals (Basel, Switzerland). 14. PMID 34832961 DOI: 10.3390/ph14111179 |
0.403 |
|
| 2021 |
Kindler D, Maschio C, Ni R, Zerbi V, Razansky D, Klohs J. Arterial spin labeling demonstrates preserved regional cerebral blood flow in the P301L mouse model of tauopathy. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211062274. PMID 34822744 DOI: 10.1177/0271678X211062274 |
0.39 |
|
| 2021 |
Zhou R, Ji B, Kong Y, Qin L, Ren W, Guan Y, Ni R. PET Imaging of Neuroinflammation in Alzheimer's Disease. Frontiers in Immunology. 12: 739130. PMID 34603323 DOI: 10.3389/fimmu.2021.739130 |
0.379 |
|
| 2021 |
Ni R, Villois A, Dean-Ben XL, Chen Z, Vaas M, Stavrakis S, Shi G, deMello A, Ran C, Razansky D, Arosio P, Klohs J. and characterization of CRANAD-2 for multi-spectral optoacoustic tomography and fluorescence imaging of amyloid-beta deposits in Alzheimer mice. Photoacoustics. 23: 100285. PMID 34354924 DOI: 10.1016/j.pacs.2021.100285 |
0.466 |
|
| 2021 |
Kong Y, Huang L, Li W, Liu X, Zhou Y, Liu C, Zhang S, Xie F, Zhang Z, Jiang D, Zhou W, Ni R, Zhang C, Sun B, Wang J, et al. The Synaptic Vesicle Protein 2A Interacts With Key Pathogenic Factors in Alzheimer's Disease: Implications for Treatment. Frontiers in Cell and Developmental Biology. 9: 609908. PMID 34277597 DOI: 10.3389/fcell.2021.609908 |
0.359 |
|
| 2021 |
Ni R, Röjdner J, Voytenko L, Dyrks T, Thiele A, Marutle A, Nordberg A. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK1195 in Autopsy Alzheimer's Brain Tissue. Journal of Alzheimer's Disease : Jad. PMID 33749648 DOI: 10.3233/JAD-201344 |
0.593 |
|
| 2021 |
Razansky D, Klohs J, Ni R. Multi-scale optoacoustic molecular imaging of brain diseases. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33594473 DOI: 10.1007/s00259-021-05207-4 |
0.307 |
|
| 2020 |
Ni R, Chen Z, Gerez JA, Shi G, Zhou Q, Riek R, Nilsson KPR, Razansky D, Klohs J. Detection of cerebral tauopathy in P301L mice using high-resolution large-field multifocal illumination fluorescence microscopy. Biomedical Optics Express. 11: 4989-5002. PMID 33014595 DOI: 10.1364/Boe.395803 |
0.367 |
|
| 2020 |
Ni R, Zarb Y, Kuhn GA, Müller R, Yundung Y, Nitsch RM, Kulic L, Keller A, Klohs J. SWI and phase imaging reveal intracranial calcifications in the P301L mouse model of human tauopathy. Magma (New York, N.Y.). PMID 32468149 DOI: 10.1007/S10334-020-00855-3 |
0.437 |
|
| 2019 |
Ren W, Skulason H, Schlegel F, Rudin M, Klohs J, Ni R. Automated registration of magnetic resonance imaging and optoacoustic tomography data for experimental studies. Neurophotonics. 6: 025001. PMID 30989087 DOI: 10.1117/1.Nph.6.2.025001 |
0.304 |
|
| 2019 |
Ni R, Kindler DR, Waag R, Rouault M, Ravikumar P, Nitsch R, Rudin M, Camici GG, Liberale L, Kulic L, Klohs J. fMRI Reveals Mitigation of Cerebrovascular Dysfunction by Bradykinin Receptors 1 and 2 Inhibitor Noscapine in a Mouse Model of Cerebral Amyloidosis. Frontiers in Aging Neuroscience. 11: 27. PMID 30890928 DOI: 10.3389/Fnagi.2019.00027 |
0.473 |
|
| 2018 |
Ni R, Mu L, Ametamey S. Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system. Acta Pharmacologica Sinica. PMID 29921889 DOI: 10.1038/S41401-018-0035-5 |
0.403 |
|
| 2018 |
Ni R, Rudin M, Klohs J. Cortical hypoperfusion and reduced cerebral metabolic rate of oxygen in the arcAβ mouse model of Alzheimer's disease. Photoacoustics. 10: 38-47. PMID 29682448 DOI: 10.1016/J.Pacs.2018.04.001 |
0.361 |
|
| 2018 |
Ni R, Ji B, Ono M, Sahara N, Zhang MR, Aoki I, Nordberg A, Suhara T, Higuchi M. Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29419480 DOI: 10.2967/Jnumed.117.201632 |
0.6 |
|
| 2018 |
Ishikawa A, Tokunaga M, Maeda J, Minamihisamatsu T, Shimojo M, Takuwa H, Ono M, Ni R, Hirano S, Kuwabara S, Ji B, Zhang MR, Aoki I, Suhara T, Higuchi M, et al. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510. Journal of Alzheimer's Disease : Jad. 61: 1037-1052. PMID 29332041 DOI: 10.3233/Jad-170509 |
0.466 |
|
| 2018 |
Ni R, Haider A, Herde A, Klohs J, Mu L, Ametamey SM. P4-311: Evaluation Of Cannabinoid Receptor 2 Pet Imaging Tracers In Alzheimer'S Disease Brain Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.07.134 |
0.493 |
|
| 2018 |
Ni R, Vaas M, Arosio P, Klohs J. O5-01-01: IN VIVO OPTOACOUSTIC TOMOGRAPHY OF BRAIN AMYLOID DEPOSITS IN AN ARCAβ MOUSE MODEL OF ALZHEIMER'S DISEASE Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2995 |
0.509 |
|
| 2018 |
Ni R, Kindler DR, Rouault M, Ielacqua GD, Klohs J. P3-063: BRADYKININ ANTAGONIST NOSCAPINE MITIGATES CEREBROVASCULAR DYSFUNCTION IN THE ARCAβ MOUSE MODEL OF ALZHEIMER'S DISEASE Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1419 |
0.437 |
|
| 2017 |
Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M, Hozumi I, Yoshiyama Y, van Swieten JC, Nordberg A, Suhara T, et al. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. Brain : a Journal of Neurology. PMID 28087578 DOI: 10.1093/Brain/Aww339 |
0.59 |
|
| 2016 |
Ni R, Gillberg PG, Bogdanovic N, Viitanen M, Myllykangas L, Nennesmo I, Långström B, Nordberg A. Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27693181 DOI: 10.1016/J.Jalz.2016.08.006 |
0.618 |
|
| 2016 |
Ni R, Ji B, Ono M, Sahara N, Aoki I, Zhang M, Suhara T, Higuchi M. Radioligand Binding Assays For Comparison Of Tau Pet Probes, Pbb3 And T807, In Detection Of Tau Pathologies In Alzheimer'S Disease And Psp Brains, And Neurotoxic Tau Species In A Transgenic Mouse Model Alzheimers & Dementia. 12: 725. DOI: 10.1016/J.Jalz.2016.06.1426 |
0.527 |
|
| 2015 |
Rodriguez-Vieitez E, Ni R, Gulyás B, Tóth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1119-32. PMID 25893384 DOI: 10.1007/S00259-015-3047-0 |
0.596 |
|
| 2015 |
Ni R, Gillberg P, Viitanen M, Myllykangas L, Bogdanovic N, Nennesmo I, Långström B, Nordberg A. P4-254: Characterization of regional binding of clinical amyloid tracers in autosomal dominant and sporadic Alzheimer's disease brains and their interactions with resveratrol Alzheimer's & Dementia. 11: P878-P878. DOI: 10.1016/J.Jalz.2015.08.083 |
0.601 |
|
| 2014 |
Ni R, Rodriguez-Vieitez E, Voytenko L, Marutle A, Nordberg A. Different Time Course Of Astrocytosis And Amyloid Deposition In Alzheimer'S Appswe Transgenice Mice: A Multi-Tracer Micropet Study Alzheimers & Dementia. 10: 253. DOI: 10.1016/J.Jalz.2014.04.394 |
0.575 |
|
| 2013 |
Marutle A, Gillberg PG, Bergfors A, Yu W, Ni R, Nennesmo I, Voytenko L, Nordberg A. ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain. Journal of Neuroinflammation. 10: 90. PMID 23880036 DOI: 10.1186/1742-2094-10-90 |
0.645 |
|
| 2013 |
Ni R, Gillberg PG, Bergfors A, Marutle A, Nordberg A. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue. Brain : a Journal of Neurology. 136: 2217-27. PMID 23757761 DOI: 10.1093/Brain/Awt142 |
0.567 |
|
| 2013 |
Choo IH, Ni R, Schöll M, Wall A, Almkvist O, Nordberg A. Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients. Journal of Alzheimer's Disease : Jad. 33: 929-39. PMID 23047371 DOI: 10.3233/Jad-2012-121489 |
0.534 |
|
| 2013 |
Ni R, Marutle A, Nordberg A. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain. Journal of Alzheimer's Disease : Jad. 33: 841-51. PMID 23042213 DOI: 10.3233/Jad-2012-121447 |
0.602 |
|
| 2013 |
Rodriguez-Vieitez E, Ni R, Gulyás B, Toth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A. Astrocytosis precedes amyloid deposition in Alzheimer’s disease Tg2576 APPswe transgenic mice: A multitracer microPET imaging study Alzheimers & Dementia. 9: 337. DOI: 10.1016/J.Jalz.2013.04.197 |
0.562 |
|
| 2011 |
Thomé C, Ni R, Gillberg P, Marutle A, Nordberg A. P4-301: Evolution of fibrillar amyloid in relation to astro- and microgliosis and alterations in α7 nicotinic receptors in Alzheimer APPswe mice as studied with multi-tracer concept Alzheimer's & Dementia. 7: e16-e17. DOI: 10.1016/J.Jalz.2011.09.046 |
0.542 |
|
| 2011 |
Ni R, Marutle A, Nordberg A. P2-487: Alpha7 nicotinic receptor agonists interrupt the interaction between fibrillar amyloid and nicotinic receptor in Alzheimer's brain Alzheimer's & Dementia. 7: S468-S468. DOI: 10.1016/J.Jalz.2011.05.1358 |
0.512 |
|
| 2011 |
Marutle A, Bergfors A, Ni R, Nennesmo I, Gillberg P, Nordberg A. P2-329: Laminar distributions of fibrillar β-amyloid and activated astrocytes in Alzheimer's disease autopsy brain: A quantitative autoradiography study Alzheimer's & Dementia. 7: S414-S415. DOI: 10.1016/J.Jalz.2011.05.1205 |
0.59 |
|
| Show low-probability matches. |